Rx Only Takeda PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4625-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 2000 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521226 PRINCIPAL DISPLAY PANEL - Blister Label - 2000 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4625-02 Single-dose only 6521498 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
Clashes between protein and lipid atoms were reduced through 2500 conjugate-gradient minimization steps, followed by a 6 ns long MD simulation with a linearly-released positional constraint of 1 kcal mol 1 2 on protein and lipid phosphorus atoms
Tumor-associated external resistance Beyond abnormal vascularization due to tumor angiogenesis, hypoxia, and low pH induce an immunosuppressive TME 65
For depression, the usual recommended dosage is 1500 to 3000 mg (3 to 6 capsules)
Sleep disruption traced to progesterone decline responds to micronized progesterone
Niacinamide l mt dng ca vitamin B-3, mt cht dinh dng cn thit cho ln da khe mnh
